Showing results (451-460 of 493) with videos related to

Sort By:
Pageof 50
Cancer|June 20, 2001
Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignanciesT M Cao, C Kusnierz-Glaz, F Valone, et al.
Annals of Neurology|November 1, 1993
Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomideD M Karussis, D Lehmann, S Slavin, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 27, 2014
Effects of inner volume field-of-view reduction on myocardial T2 mappingFabio Gibiino, Silke Lechner-Greite, Timo Schirmer, et al.
AIDS and Behavior|November 30, 2014
Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral TherapyC E Newman, J de Wit, A Persson, et al.
Transplantation|April 15, 1996
Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patientsR Or, A Nagler, O Shpilberg, et al.
Leukemia & Lymphoma|June 1, 1999
Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphomaG Varadi, R Or, J Kapelushnik, et al.
Bone Marrow Transplantation|July 6, 2004
Low transplant-related mortality with allogeneic stem cell transplantation in elderly patientsM Y Shapira, I B Resnick, M Bitan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 1998
Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantationR Or, A Ackerstein, A Nagler, et al.
Bone Marrow Transplantation|September 4, 2003
A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantationM Y Shapira, R Or, I B Resnick, et al.
Presse Medicale (Paris, France : 1983)|January 30, 1993
[Hematopoietic growth factor (GM-CSF) after autologous bone marrow transplantation. A randomized, double-blind, multicenter study in 91 cases of non-Hodgkin's malignant lymphomas]N C Gorin, B Coiffier, M Hayat, et al.
Pageof 50